TAS2R14 agonist 28.1 (sometimes referred to simply as 28.1) is an experimental drug that acts as a potent and selective agonist of the bitter taste receptor TAS2R14. It was developed by modification of flufenamic acid, a pharmaceutical known for a foul, bitter taste which produces bitterness via activation of TAS2R14, but is around six times more potent.
TAS2R14 agonist 28.1 (sometimes referred to simply as 28.1) is an experimental drug that acts as a potent and selective agonist of the bitter taste receptor TAS2R14. It was developed by modification of flufenamic acid, a pharmaceutical known for a foul, bitter taste which produces bitterness via activation of TAS2R14, but is around six times more potent.
Source: Wikipedia "TAS2R14 agonist 28.1" · CC BY-SA 4.0
Share this article: X · Bluesky